Review: Innovative monoclonal antibody therapies in multiple sclerosis

The recent years have witnessed great efforts in establishing new therapeutic options for multiple sclerosis (MS), especially for relapsing—remitting disease courses. In particular, the application of monoclonal antibodies provide innovative approaches allowing for blocking or depleting specific mol...

Full description

Bibliographic Details
Main Authors: Ralf A. Linker, Bernd C. Kieseier
Format: Article
Language:English
Published: SAGE Publishing 2008-07-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/1756285608093945